文献速递免疫规划传染病防控与疫情报告

铜绿假单胞菌膜囊泡疫苗对角膜炎的预防与治疗作用

Prophylactic and therapeutic vaccine against Pseudomonas aeruginosa keratitis using bacterial membrane vesicles.
PubMed 文献 · Vaccine · 2021-04-30

本研究在C57BL/6小鼠中探索铜绿假单胞菌膜囊泡(MVs)作为预防性疫苗以及MV免疫血清作为治疗手段对铜绿假单胞菌角膜炎的效果。结果显示,肌内免疫诱导的血清和眼洗液中均可检测到特异性IgG和IgA,主动和被动免疫均显著抑制角膜感染,且对已建立感染的眼表局部应用免疫血清可降低临床评分和细菌载量。

要点

  • 铜绿假单胞菌MVs肌内免疫可诱导血清和眼表特异性IgG、IgA。
  • 主动和被动免疫均能显著抑制小鼠角膜铜绿假单胞菌感染。
  • 对已感染眼局部应用免疫血清可降低角膜临床评分和细菌载量。

核心结论

  • 铜绿假单胞菌MVs疫苗接种及局部应用MV特异性免疫血清可减轻铜绿假单胞菌角膜炎。

研究设计与样本

  • 研究使用C57BL/6小鼠,肌内免疫铜绿假单胞菌MVs,角膜划痕后局部感染多株铜绿假单胞菌。
  • 被动免疫采用铜绿假单胞菌MV免疫的ICR小鼠血清腹腔注射至naïve C57BL/6小鼠,随后角膜攻击。
  • 免疫血清也用于已建立铜绿假单胞菌角膜感染小鼠的局部治疗。

主要发现

  • 肌内免疫诱导的铜绿假单胞菌特异性IgG和IgA抗体在血清和眼洗液中均可检测到。
  • 主动和被动免疫均显著抑制铜绿假单胞菌角膜感染。
  • 对已建立角膜感染的小鼠局部应用免疫血清,角膜临床评分和角膜细菌载量显著降低。

临床怎么用

  • 提示铜绿假单胞菌MVs可作为预防角膜炎的候选疫苗。
  • MV特异性免疫血清局部应用可能成为铜绿假单胞菌角膜炎的治疗选择。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Pseudomonas aeruginosa (P. aeruginosa) infection is one of the major causes of keratitis. However, effective prophylactic and therapeutic vaccines against P. aeruginosa keratitis have yet to be developed. In this study, we explored the use of P. aeruginosa membrane vesicles (MVs) as a prophylactic vaccine as well as the use of immune sera derived from P. aeruginosa MV-immunized animals as a treatment for P. aeruginosa corneal infections in C57BL/6 mice. METHODS: C57BL/6 mice were intramuscularly immunized with P. aeruginosa MVs; the mouse corneas were then scarified and topically infected with several P. aeruginosa strains, followed by determination of corneal clinical score and corneal bacterial load. Next, immune sera derived from P. aeruginosa MV-immunized ICR mice were administered intraperitoneally to naïve C57BL/6 mice, followed by topical P. aeruginosa challenge. Finally, the immune sera were also used as a topical treatment in the mice with established P. aeruginosa corneal infections. RESULTS: P. aeruginosa-specific IgG and IgA antibodies induced by intramuscular immunization were detected not only in the sera but also in the eye-wash solution. Both active and passive immunization significantly inhibited P. aeruginosa corneal infection. Finally, topical treatment with immune sera in the mice with established P. aeruginosa corneal infections notably decreased the corneal clinical score and corneal bacterial load. CONCLUSIONS: P. aeruginosa keratitis can be attenuated by vaccination of P. aeruginosa MVs and topical application of P. aeruginosa MV-specific immune sera.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Ito S, Nakamura J, Fukuta M, et al. Prophylactic and therapeutic vaccine against Pseudomonas aeruginosa keratitis using bacterial membrane vesicles. Vaccine. 2021. PMID: 33934918. doi:10.1016/j.vaccine.2021.04.035

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。